PRASANNA SUGATHAN

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease LAKE CHARLES, LA NPI 1598847733

General Payments — all program years on this page

$2,320.46

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 56
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $571.42 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $571.4219

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $375.565
2019 $74.351
2020 $170.332
2022 $447.2911
2023 $681.5118
2024 $571.4219

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1080681266 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $9.89 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080681268 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $11.36 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087266993 Novartis Pharmaceuticals Corporation $29.81 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087266995 Novartis Pharmaceuticals Corporation $1.86 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087266997 Novartis Pharmaceuticals Corporation $18.17 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087266999 Novartis Pharmaceuticals Corporation $15.27 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087267001 Novartis Pharmaceuticals Corporation $13.32 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087267003 Novartis Pharmaceuticals Corporation $10.51 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087267005 Novartis Pharmaceuticals Corporation $4.20 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087267007 Novartis Pharmaceuticals Corporation $27.37 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087267009 Novartis Pharmaceuticals Corporation $21.23 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087267011 Novartis Pharmaceuticals Corporation $23.44 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092587011 Boston Scientific Corporation $29.03 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092587013 Boston Scientific Corporation $35.72 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101405219 E.R. Squibb & Sons, L.L.C. $17.22 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129456928 Esperion Therapeutics, Inc. $110.53 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132868316 ATRICURE, INC. $27.63 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132900694 ATRICURE, INC. $19.34 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154170642 HEARTFLOW, INC. $145.52 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.